CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus - Wikidata - awgldk - TriplyDB

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

http://www.wikidata.org/entity/Q34478938

about

CRISPR/Cas9 and cancer targets: future possibilities and present challenges Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases Application of CRISPR/Cas9 Technology to HBV A CRISPR toolbox to study virus-host interactions Genome editing and the next generation of antiviral therapy.Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems.Applications of CRISPR technologies in research and beyond.Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape.Optimization of a multiplex CRISPR/Cas system for use as an antiviral therapeutic A CRISPR/Cas9 and Cre/Lox system-based express vaccine development strategy against re-emerging Pseudorabies virus.Harnessing the Prokaryotic Adaptive Immune System as a Eukaryotic Antiviral Defense.Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus.An Effective Molecular Target Site in Hepatitis B Virus S Gene for Cas9 Cleavage and Mutational Inactivation Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9 CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.Removal of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9.Transgenic Clustered Regularly Interspaced Short Palindromic Repeat/Cas9-Mediated Viral Gene Targeting for Antiviral Therapy of Bombyx mori Nucleopolyhedrovirus.Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV.CRISPR Editing in Biological and Biomedical Investigation.Developmental history and application of CRISPR in human disease.Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.New therapies for chronic hepatitis B.A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.Experimental models of hepatitis B and C - new insights and progress CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.The current status and future directions of hepatitis B antiviral drug discovery.Inhibiting cyprinid herpesvirus-3 replication with CRISPR/Cas9.The expanding footprint of CRISPR/Cas9 in the plant sciences.The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models CRISPR-Cas9 technology: applications and human disease modelling.Therapeutic applications of CRISPR RNA-guided genome editing.CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.Advancement of the Emerging Field of RNA Nanotechnology.The discovery and development of the CRISPR system in applications in genome manipulation.Use of CRISPR/Cas9 to model brain diseases.The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.Virus-host interplay in hepatitis B virus infection and epigenetic treatment strategies.CRISPR/Cas9: at the cutting edge of hepatology.Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.

P2860

Q26769907-5DC6C92B-3051-49BA-9344-35E8A038AB9B Q26778992-5595CFB1-38D0-427F-9B25-2E7B3FD20E10 Q26779150-816AE792-56D0-49FF-B29B-05B56697D210 Q29994612-AF4D1ECF-C586-47BC-8D33-99C461ECE609 Q34529971-BF396E2F-44BD-417E-929B-D61821102015 Q34536517-59E58E8B-83FE-40FB-AFDA-1C898C42D5FA Q34539796-519D557A-469C-4344-A439-A583E34CA717 Q36216276-C28B8C81-2B2C-4D24-B242-A31C3382DB7D Q36386251-23376E66-BD6B-4CFE-AABC-7915C9581B5B Q36499967-3BF718A6-C28E-4E7F-BECF-073DB4233403 Q36730743-10927A7A-6A75-4D3C-AE8E-1A7A1F3BD040 Q36951290-2A4BC272-F31C-4BFB-91B5-6FE494AA2BE9 Q37201993-69DE710C-02F5-47AF-8338-EB387E75789E Q37411994-A75AF79F-E14B-44B7-91E5-D1B0DDB40BB9 Q37559174-2146EC91-82E2-41AA-9E45-48738409200B Q37714431-620C9870-5B25-45D7-B082-0D287C3C25DF Q37732408-19C525A9-DF0F-4757-ABA7-CA19F8E18FDE Q38566445-A85BDFA8-543E-4FE7-A724-EF2487E75C8F Q38618922-50ADE024-7959-4E82-AA20-24DCEC1F9291 Q38645581-BEDB953B-2084-4116-B0B8-16B1B9C533AB Q38669948-DC1B0967-4E89-4CF3-BCCE-A1EC2B4D0C21 Q38700979-47A167A5-66E5-4620-B14C-1783333662BC Q38725759-D7E13E87-7945-4417-A67C-18161D15F29F Q38759997-9ADDABC6-73E0-4993-BCC5-350404B97B9C Q38778496-AD589203-F75C-489D-885D-CDD5724C40D4 Q38800708-A59F5190-DC2B-4578-9CE8-FF95496F53A2 Q38802098-033DA02F-1078-4AD8-9757-F9E892117125 Q38808342-718F41A2-815E-45AA-95A9-1188D5619D23 Q38823331-E89B21A1-AE82-41E0-82CF-7D609498FE13 Q38836751-C124AE0B-7BAA-4FCF-948B-05A808CDEA34 Q38848400-D094A2FF-B8C8-4966-AFDB-EDC33BA01C24 Q38937607-E0E26A2D-2BAD-4916-B812-3CD5078EF6FF Q39014648-12583269-64FA-4EB7-8AED-708712993556 Q39065708-804006E1-235E-41C5-8955-86D4A035857D Q39095111-B8FCEDAF-674E-4BBF-8632-A7FF3A3B651F Q39230334-B6D90BC5-E90C-4F81-B947-0C4B9EE42491 Q39260698-D2F6ACAF-D346-4210-82E1-0E59DB6A06C3 Q39272853-F8F3E09F-CCE2-404C-8E0A-09A1F2D12193 Q39294371-5CE2D507-D7B4-4AA1-BE75-9C2B8964F75B Q40040519-F5B4F479-A462-4D45-B6C9-141BDF2ABA5C

P2860

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

http://www.wikidata.org/entity/Q34478938

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

@ast

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

@en

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

@nl

type

label

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

@ast

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

@en

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

@nl

prefLabel

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

@ast

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

@en

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

@nl

P1433

Q34478938-C9203BD1-2C0D-46CE-B13E-40433FBDD9A1

P1476

Q34478938-163EA3D8-BA5F-44A5-A820-B9A411CB65C8

P2093

Q34478938-00EC4DD8-AA60-42A9-B50B-1C630DF97A6B

Q34478938-355822BD-BD9A-4007-85AA-721B968B6D9D

Q34478938-65071EB4-B70A-482E-B6F8-10535A286C03

Q34478938-78809F36-BFDC-448A-B8A4-61DD9FFE68CA

Q34478938-89EF88E9-1CD4-4956-A84E-1CDE07DCC23C

Q34478938-DA001F19-5D12-48C9-B446-98156DA1DD26

Q34478938-FEBA9003-8A3D-4020-A45C-6B37DF5BEF15

P2860

Q34478938-001D74C1-D933-489D-BF68-9616AD13930C

Q34478938-0482DC1E-55EE-4E87-8928-1C0FBA6019C4

Q34478938-1CA58440-C74E-4786-902A-5F02BD5ABE2C

Q34478938-25A3395B-7A91-46A6-B78E-3470875D870B

Q34478938-28057665-7691-486E-A529-BAAA79CA0EEC

Q34478938-2AD38AF3-4A77-417B-B1CE-59FEAEB157F0

Q34478938-371E4908-F009-4FEB-828A-AD06B3A3F6B4

Q34478938-44CC6915-990C-49CB-A0BE-68E29143483F

Q34478938-531D7C43-DF91-40B8-9B1E-156258EB8308

Q34478938-5D08EA0D-BC1B-4175-B774-01B4078E3294

P2888

Q34478938-F1DC5E8E-57B8-4728-8CE6-7B0BAA0A0327

P304

Q34478938-0B01182A-B54C-4056-A094-61FF2563873D

P31

Q34478938-EC990F04-861D-4BAE-881F-C592803C3CD0

P356

Q34478938-AB28F0EA-D2C4-44E2-BD61-87E0ADB415B1

P407

Q34478938-28217C69-580C-4453-8C7B-F93F45145062

P478

Q34478938-DB061210-C00A-4A54-8539-FF537211A1AE

P50

Q34478938-4A1B991F-4318-41D9-9556-CD76DD87740D

Q34478938-4A8AFC02-53F7-4002-A812-80826CA83998

Q34478938-847A4083-6A2A-4FC9-8929-CDAFF8D33DA6

P577

Q34478938-A865891D-5EF2-4068-9CD7-8464FCE977CC

P5875

Q34478938-ADD10568-61A5-4CF5-BCF3-81844CD06D92

P6179

Q34478938-35DC0419-D865-4B2C-80F6-86F94EB5A085

P698

Q34478938-377E427B-F730-4395-AF97-D749646381AD

P921

Q34478938-C8C9185E-23A1-4061-ABC5-806854B4BB67

P932

Q34478938-E85C9E81-FDCC-4D31-81A9-21D020EF1982

P356

P1433

Scientific Reports

P1476

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

@en

P2093

Ankit Bhatta

http://www.w3.org/2001/XMLSchema#string

Charles M Rice

http://www.w3.org/2001/XMLSchema#string

David A Scott

http://www.w3.org/2001/XMLSchema#string

David B T Cox

http://www.w3.org/2001/XMLSchema#string

Feng Zhang

http://www.w3.org/2001/XMLSchema#string

Robert E Schwartz

http://www.w3.org/2001/XMLSchema#string

Sangeeta N Bhatia

http://www.w3.org/2001/XMLSchema#string

P2860

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

RNA-guided human genome engineering via Cas9

Multiplex genome engineering using CRISPR/Cas systems

Therapeutic genome editing: prospects and challenges

Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression

DNA targeting specificity of RNA-guided Cas9 nucleases

Genome-scale CRISPR-Cas9 knockout screening in human cells

CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea

CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences

RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.

P2888

P304

10833

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP10833

http://www.w3.org/2001/XMLSchema#string

P407

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Eleftherios Michailidis

P577

2015-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279155580

http://www.w3.org/2001/XMLSchema#string

P6179

1004593815

http://www.w3.org/2001/XMLSchema#string

P698

26035283

http://www.w3.org/2001/XMLSchema#string

P921

P932

4649911

http://www.w3.org/2001/XMLSchema#string